15 results
8-K
EX-99.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
8 May 24
Maravai Lifesciences Reports First Quarter 2024 Financial Results
4:09pm
current or future products.
The risk that a future cyber-attack or security breach cannot be prevented.
Maravai’s ability to protect
8-K
EX-2.1
MRVI
Maravai LifeSciences Holdings Inc - Ordinary Shares
10 Aug 21
Maravai Lifesciences Reports Second Quarter Financial Results and Updates 2021 Financial Guidance
4:18pm
or threatened Security Incident or cyber attack, including, but not limited to a ransomware attack or a denial-of-service attack. No Acquired Company … material respects. The Acquired Companies maintain, and have in the past three (3) years maintained, cyber liability insurance with reasonable coverage
10-K
7939chjxb
22 Mar 21
Annual report
4:22pm
8-K
EX-1.1
uswqm1nyy1xo94ahij
25 Nov 20
Maravai LifeSciences Announces Closing of Initial Public Offering and Full Exercise of the Underwriters’ Option to
8:03am
424B4
ev60uruf8vy
23 Nov 20
Prospectus supplement with pricing info
4:36pm
S-1
ei96sv
29 Oct 20
IPO registration
5:04pm
DRS/A
n4et5n6jj 5yf3w3ik
23 Oct 20
Draft registration statement (amended)
12:00am
DRS/A
ykzow3ti7rg59cex4
14 Oct 20
Draft registration statement (amended)
12:00am
DRS
t12cwvqk bkwhzvnbd
8 Sep 20
Draft registration statement
12:00am
- Prev
- 1
- Next